94 related articles for article (PubMed ID: 30265158)
1. Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis.
Wang Z; Zou F; Tian Y; Xiang B; Qin B; Liu Y
Future Oncol; 2018 Nov; 14(26):2701-2712. PubMed ID: 30265158
[TBL] [Abstract][Full Text] [Related]
2. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
[TBL] [Abstract][Full Text] [Related]
3. AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel.
Wu G; Qin XQ; Guo JJ; Li TY; Chen JH
Int J Clin Exp Pathol; 2014; 7(4):1449-58. PubMed ID: 24817940
[TBL] [Abstract][Full Text] [Related]
4. DUSP1 induces paclitaxel resistance through the regulation of p-glycoprotein expression in human ovarian cancer cells.
Kang YS; Seok HJ; Jeong EJ; Kim Y; Yun SJ; Min JK; Kim SJ; Kim JS
Biochem Biophys Res Commun; 2016 Sep; 478(1):403-409. PubMed ID: 27422607
[TBL] [Abstract][Full Text] [Related]
5. Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
Zuo Q; Liu J; Zhang J; Wu M; Guo L; Liao W
Sci Rep; 2015 Jun; 5():11634. PubMed ID: 26108989
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.
Kang Y; Nagaraja AS; Armaiz-Pena GN; Dorniak PL; Hu W; Rupaimoole R; Liu T; Gharpure KM; Previs RA; Hansen JM; Rodriguez-Aguayo C; Ivan C; Ram P; Sehgal V; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK
Clin Cancer Res; 2016 Apr; 22(7):1713-24. PubMed ID: 26581245
[TBL] [Abstract][Full Text] [Related]
7. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer.
Teng F; Xu Z; Chen J; Zheng G; Zheng G; Lv H; Wang Y; Wang L; Cheng X
Oncol Rep; 2018 Sep; 40(3):1203-1222. PubMed ID: 29956792
[TBL] [Abstract][Full Text] [Related]
8. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
9. An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.
Piro G; Carbone C; Cataldo I; Di Nicolantonio F; Giacopuzzi S; Aprile G; Simionato F; Boschi F; Zanotto M; Mina MM; Santoro R; Merz V; Sbarbati A; de Manzoni G; Scarpa A; Tortora G; Melisi D
Clin Cancer Res; 2016 Dec; 22(24):6164-6175. PubMed ID: 27267856
[TBL] [Abstract][Full Text] [Related]
10. Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1.
Nonagase Y; Yonesaka K; Kawakami H; Watanabe S; Haratani K; Takahama T; Takegawa N; Ueda H; Tanizaki J; Hayashi H; Yoshida T; Takeda M; Chiba Y; Tamura T; Nakagawa K; Tsurutani J
Oncotarget; 2016 Dec; 7(51):84860-84871. PubMed ID: 27768588
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells.
Abuharbeid S; Apel J; Zugmaier G; Knabbe C; Sander M; Gilbert S; Czubayko F; Aigner A
Naunyn Schmiedebergs Arch Pharmacol; 2005 Feb; 371(2):141-51. PubMed ID: 15700118
[TBL] [Abstract][Full Text] [Related]
12. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
[TBL] [Abstract][Full Text] [Related]
13. Increasing HER2 α2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.
Liu N; Zhu M; Linhai Y; Song Y; Gui X; Tan G; Li J; Liu Y; Deng Z; Chen X; Wang J; Jia L; He X; Wang X; Lin S
Oncol Rep; 2018 Nov; 40(5):2997-3005. PubMed ID: 30226606
[TBL] [Abstract][Full Text] [Related]
14. The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab.
Eto K; Iwatsuki M; Watanabe M; Ida S; Ishimoto T; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
Ann Surg Oncol; 2014 Jan; 21(1):343-50. PubMed ID: 24154840
[TBL] [Abstract][Full Text] [Related]
15. TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Mercogliano MF; De Martino M; Venturutti L; Rivas MA; Proietti CJ; Inurrigarro G; Frahm I; Allemand DH; Deza EG; Ares S; Gercovich FG; Guzmán P; Roa JC; Elizalde PV; Schillaci R
Clin Cancer Res; 2017 Feb; 23(3):636-648. PubMed ID: 27698002
[TBL] [Abstract][Full Text] [Related]
16. EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.
Yoon S; Choi JH; Kim SJ; Lee EJ; Shah M; Choi S; Woo HG
Exp Mol Med; 2019 Jun; 51(6):1-12. PubMed ID: 31160603
[TBL] [Abstract][Full Text] [Related]
17. Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis.
Murakami H; Ito S; Tanaka H; Kondo E; Kodera Y; Nakanishi H
Anticancer Res; 2013 Oct; 33(10):4299-307. PubMed ID: 24122996
[TBL] [Abstract][Full Text] [Related]
18. A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway.
Liu J; Pan C; Guo L; Wu M; Guo J; Peng S; Wu Q; Zuo Q
J Hematol Oncol; 2016 Aug; 9(1):76. PubMed ID: 27581375
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
20. TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells.
Kwon CH; Park HJ; Choi Y; Won YJ; Lee SJ; Park DY
Tumour Biol; 2017 Oct; 39(10):1010428317722070. PubMed ID: 28982309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
